SLC30A9 and cervical carcinoma: Furthermore, both proliferation (measured by nuclear EdU incorporation, Fig. S7D) and migration (measured by “Transwell” assays, Fig. S7E) were elevated in both primary and immortalized cervical cancer cells following SLC30A9 overexpression.